The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package.
Please note: there are various version of this report if you click on the file!
This is the second civil society-led monitoring report produced by Correlation – European Harm Reduction Network (C-EHRN). The purpose of this report is to enrich the information and knowledge base of harm reduction interventions in Europe from the viewpoint of civil society organisations. The Monitoring report gathers data on the experiences of harm reduction service providers and service users at ground level, building on a network of national Focal Points (FPs) in Europe. For the 2020 monitoring, C-EHRN includes 35 FPs in 34 countries. To get insight at the implementation level, and to profit from the experiences and expertise of FPs, the 2020 monitoring focuses mostly on cities rather than countries. The main areas monitored are: essential harm reduction services, overdose prevention, Hepatitis C, New drug Trends, Civil Society Involvement and COVID-19 impact on harm reduction services and people who use drugs.
The aim of this report is to provide an overview of generic national health emergency responses to public health threats and to identify mechanisms that may be applicable to synthetic opioid preparedness. This inventory will enable us to learn from generic health emergency crises, such as food-borne diseases, flew pandemics, and environmental crises, as well as from the health emergency program EU Joint Action SHARP.
The aim of this report is to provide an overview of synthetic opioid preparedness protocols and strategies of different EU Member States and to identify needs and challenges across the EU. This will be done by means of a review of the literature and a questionnaire to the EMCDDA Reitox Focal Points, both investigating existing practices of synthetic opioid preparedness. In addition to that, the findings will be discussed with key experts in the field to identify needs and challenges in synthetic opioid preparedness.